12-102894798-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP4BP4
This summary comes from the ClinGen Evidence Repository: PAH-specific ACMG/AMP criteria applied: BP4: Tolerated in SIFT, benign in Polyphen-2, Polymorphism in MutationTaster. REVEL=0.511; PP4: Seen in patient with mild HPA (PMID:17627389). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BP4, PP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA6748987/MONDO:0009861/006
Frequency
Consequence
NM_000277.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAH | NM_000277.3 | c.289A>C | p.Ile97Leu | missense_variant | 3/13 | ENST00000553106.6 | NP_000268.1 | |
LOC124902999 | XR_007063428.1 | n.863-9900T>G | intron_variant, non_coding_transcript_variant | |||||
PAH | NM_001354304.2 | c.289A>C | p.Ile97Leu | missense_variant | 4/14 | NP_001341233.1 | ||
PAH | XM_017019370.2 | c.289A>C | p.Ile97Leu | missense_variant | 3/7 | XP_016874859.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAH | ENST00000553106.6 | c.289A>C | p.Ile97Leu | missense_variant | 3/13 | 1 | NM_000277.3 | ENSP00000448059 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251446Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135894
GnomAD4 exome AF: 0.0000458 AC: 67AN: 1461826Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 727218
GnomAD4 genome AF: 0.000525 AC: 80AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000551 AC XY: 41AN XY: 74444
ClinVar
Submissions by phenotype
Phenylketonuria Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 20, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 97 of the PAH protein (p.Ile97Leu). This variant is present in population databases (rs142516271, gnomAD 0.2%). This missense change has been observed in individual(s) with mild hyperphenylalaninemia (PMID: 17627389). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 376937). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PAH protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, reviewed by expert panel | curation | ClinGen PAH Variant Curation Expert Panel | Aug 07, 2018 | PAH-specific ACMG/AMP criteria applied: BP4: Tolerated in SIFT, benign in Polyphen-2, Polymorphism in MutationTaster. REVEL=0.511; PP4: Seen in patient with mild HPA (PMID:17627389). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BP4, PP4). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jan 25, 2017 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 07, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 12, 2024 | Variant summary: PAH c.289A>C (p.Ile97Leu) results in a conservative amino acid change located in the ACT domain (IPR002912) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00016 in 251446 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in PAH causing Phenylalanine Hydroxylase Deficiency (Phenylketonuria) (0.00016 vs 0.0079), allowing no conclusion about variant significance. c.289A>C has been reported in the literature in individuals affected with persistent hyperphenylalaninemia. These report(s) do not provide unequivocal conclusions about association of the variant with Phenylalanine Hydroxylase Deficiency (Phenylketonuria). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30311390, 17627389). ClinVar contains an entry for this variant (Variation ID: 376937). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Apr 25, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at